ArticleWorld journal of emergency surgery : WJES2025
Impact on the prognosis with the creation of a dedicated stroke to mesenteric ischaemia.
Article in World journal of emergency surgery : WJES, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive factors for mortality in acute mesenteric ischemia.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute mesenteric ischaemia (AMI) is an emergency with a poor prognosis. In France, a structure dedicated to AMI has been created in Paris in 2016 (SURVI), with promising results. A similar organization has been created in Marseille in 2021 (SOS AMI). Our aim was to compare the results of SOS AMI with those of a previous cohort of AMI patients managed without any dedicated structure.
methodsThe first 100 patients with AMI, managed by the SOS AMI, between November 2021 and December 2023 were prospectively included. They were compared with 100 AMI patients from a previous retrospective cohort (from January 2017 to December 2020), managed without any dedicated structure in the same center.
resultsThe first 100 AMI patients managed by SOS AMI have similar demographic characteristics to those previously managed without SOS. The vascular causes of AMI were also similar between groups: arterial occlusive (61 vs. 56%, p = 0.5), venous occlusive (17 vs. 13%, p = 0.5), or non occlusive (22 vs. 31%, p = 0.2). AMI patients managed by SOS AMI were more frequently transferred from another center (41 vs. 19%, p = 0.001), had a shorter median time between CT scan and intervention (4 [range, 1-129] vs. 5 [0-285] hours, p = 0.05), a higher revascularisation rate (61 vs. 28%, p = 0.02), and lower 30-day (32 vs. 58%, p < 0.001) and 90-day (45 vs. 62%, p = 0.02) mortality rates.
conclusionThe creation of SOS AMI has significantly improved the management of AMI patients, by better organizing the role of the various specialties involved, particularly in terms of revascularisation and survival rates. These promising results support the further development and expansion of this dedicated structure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.